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Abstract
Evidence-based medicine (EBM) is seen as integral to modern medical science and practice, yet perceptions persist that there 
is a direct conflict between evidence-based and complementary and integrative medicine (CIM) models of patient care. Many 
practitioners fear that application of evidence-based philosophies to clinical practice may encourage therapeutic approaches 
that are reductionist (rather than holistic) and allopathic (rather than e.g. naturopathic), as well as eroding clinical autonomy by 
promoting ‘cookbook’ medicine over individualised care. These fears may be unfounded, as scientific inquiry has always been a 
core part of CIM practice. Founders of CIM professions highly valued the development and dissemination of research, as well as the 
development of higher clinical and education standards that evolved the professions. Although this has led to increasing research 
into CIM, the development of an evidence base for CIM needs to be appropriate, and respectful of the philosophy in which CIM 
is practiced. Such research suggests it is the traditional elements of practice that demonstrate the most benefit to patients when 
critically evaluated. Whilst new therapies are not without value, and the incorporation of these remain critical to the development of 
CIM professions, CIM may work best in an EBM model of healthcare when practice is focused upon tradition and philosophy. This 
discussion paper draws from a large body of work to highlight that only by truly respecting, valuing and incorporating tradition and 
philosophy can CIM be EBM, and the full promise of CIM realised. 
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BACKGROUND
A senior resident, a junior attending physician, a 
senior attending physician, and an emeritus professor 
were discussing evidence-based medicine over lunch in 
a hospital cafeteria. “EBM,” announced the resident 
with some passion, “is a revolutionary development 
in medical practice.” She went on to describe EBM’s 
fundamental innovations in solving patient problems. 
“A compelling exposition,” remarked the emeritus 
professor. “Wait a minute,” the junior attending 
exclaimed with some heat, and then proceeded to present 
an alternative position: that EBM has merely provided 
a set of additional tools for traditional approaches to 
patient care. “You make a strong and convincing case,” 
the emeritus professor commented. “Something’s wrong 
here,” the senior attending exclaimed to her older 
colleague, “their positions are diametrically opposed. 
They can’t both be right.” The emeritus professor 
looked thoughtfully at the puzzled doctor and, with the 
barest hint of a smile, replied, “Come to think of it, 
you’re right too.” 1
Evidence-based medicine (EBM) is an often poorly 
understood and maligned concept. Although only 
recently formalised, the concepts and principles of 
evidence-based medicine have a long history, with 
the documented espousal of evidence-based medicine 
principles (including the first documented  description 
of a clinical trial) dating back at least to the writings of 
noted 10th century Islamic physician Avicenna, writings 
which went on to dominate Western medical training 
for over 650 years.2 In medicine, placebo controls were 
used in research as early as 1784, when a control was 
employed to explore (and later disprove) the medical 
effects of magnetism, a popular therapeutic system of the 
time,3 but their political use predates their clinical use, 
being used by progressive Catholics in the 16th century to 
discredit right-wing exorcisms.4 
Complementary and integrative medicine has often 
been held to have long had a turbulent and tumultuous 
relationship with EBM. Internal critics have posited 
that EBM cannot co-exist with the philosophical and 
methodological underpinnings of CIM,5 whereas external 
critics have used similar arguments to suggest that CIM 
has little validity in contemporary health practice.6 Both 
arguments are incongruent with the reality of EBM. In 
truth, EBM aligns with the safe, effective and competent 
practice of any health practice, be it CIM or conventional 
medicine, and the notion that traditional knowledge and 
scientific process cannot co-exist is absurd. EBM is 
neither the bogeyman many detractors would paint it 
out to be, nor is it the rigid, inflexible system that many 
EBM ‘proponents’ (who, in reality, are not supporting 
real EBM at all) hold it to be. This article will highlight 
the importance of EBM in modern CIM practice, and 
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discuss how science and tradition can align to achieve 
ultimate patient outcomes.  
What is evidence-based medicine?
The concept of EBM simply focuses on ensuring that 
clinical decisions about individual patients are made on 
the basis of the most up-to-date, solid, reliable, scientific 
evidence. Sackett’s long-standing simple definition – 
employed by many – is that “EBM is the conscientious 
explicit and judicious use of the current best evidence in 
making decisions about the care of individual patients” 
.7 All parts of this sentence are important. “Current best 
evidence” is just that – not perfect evidence, but simply 
the best up-to-date current evidence, not evidence that is 
out of date. And evidence extends not only to that found 
in academic journals, but also that observed through 
clinical practice, uncovered through clinical expertise 
and even that found in long-standing traditions of safe 
and effective practice. This evidence must be applied 
in a “conscientious” (i.e. being careful and thorough in 
all aspects of care), “explicit” (i.e. clinicians must be 
open, clear, ‘up-front’ and transparent with patients in all 
aspects of their care) and “judicious” (i.e. good judgement 
and common sense must be used in all clinical decision-
making processes). And of course, it must be applied 
to “individual” patients – including being respective of 
individual patient beliefs and preferences. 
Figure 1: The EBM ‘Triad’
The ‘father’ of evidence-based medicine (David 
Sackett) warned against the dogmatic application of 
evidence-based medicine, noting that “good doctors use 
both individual clinical expertise and the best available 
external evidence, and neither alone is enough. Without 
clinical expertise, practice risks becoming tyrannised by 
evidence, for even excellent external evidence may be 
inapplicable to or inappropriate for an individual patient. 
Without current best evidence, practice risks becoming 
rapidly out of date, to the detriment of patients”.7 At a 
clinical level, the defining features of real EBM are: 
making ethical care of the patient the top clinician priority; 
demanding individualised evidence in a form that both the 
clinician and patient can understand; being characterised 
by expert judgement rather than the following of 
mechanical rules; and sharing clinical decision-making 
with patients via meaningful conversations.8
Evidence-based medicine in practice: key 
concepts
The key concepts of EBM in practice are not dissimilar 
to the concepts of good clinical practice in CIM. Indeed, 
many practitioners will recognise many of the following 
concepts from their own practice. In practice, EBM 
requires that treatment be individualised:
Individualised treatment
One of the principal tenets of EBM is the encouragement 
of individualised treatment. Although EBM is often 
decried as encouraging “cookbook” medicine, this arises 
from the discredited ‘mechanical-rule’ interpretation of 
EBM, real EBM actually encourages an individualised 
approach.8 The confusion possibly stems from EBM’s 
use of protocols and clinical algorithms, which are often 
erroneously conflated as being “cookbook” medicine. 
However, while “cookbook” medicine provides a recipe 
of individual treatments that all patients within a sub-
population must be prescribed (for example, every 
patient with dysmenorrhoea must be prescribed Vitex 
agnus castus), “protocols” simply provide a standardised 
roadmap to treatment (for example, ensuring that relevant 
differential diagnostic considerations are undertaken by 
performing relevant physical and diagnostic examinations, 
that social and physical factors are considered, and that all 
treatment groups have been considered). 
Similarly, EBM eschews the use of “shotgun” 
approaches to treatment, whereby a prescription is 
provided that is so broad that it covers all possible bases, 
without differentiating what the patient actually needs. 
“Shotgun” approaches to care not only needlessly expose 
patients to unnecessary clinical (i.e. potential interactions) 
and financial risk (which can result in resource constraints 
which make patients deter other necessary care), 9 they 
compromise quality continuity of care by making it 
difficult to ascertain which individual aspects of their 
treatment are actually working, making ongoing patient 
management problematic. They are also – to put it bluntly 
– an affront to the expertise of the clinician, as they ignore 
the clinician’s important role in tailoring an individualised 
prescription for the patient that is most likely to result in 
improved outcomes. They are also rarely as effective as 
individualised approaches to care.10  
These “shotgun” approaches are also worryingly 
present in many ‘wellness’ prescriptions – not true wellness 
prescriptions, but those commercialised programs 
advising unnecessary use of a multitude of supplements 
without clinical justification, with prescriptions that vary 
little between individual patients. In some cases, provision 
of even seemingly benign unnecessary treatment can even 
result in side-effects that may mimic clinical symptoms 
– for example, a British woman had been unsuccessfully 
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been seeking treatment for unexplained peripheral 
neuropathy for 10 years as a result of a preventive ‘shotgun’ 
prescription approach to wellness prescribed by a health 
food store employee.11 Her symptoms immediately ceased 
on cessation of pyridoxine-containing supplements, but 
not after considerable resources had been expended on 
finding a cure for her symptoms. Similarly, recent meta-
analyses suggesting risks from preventative one-size-fits-
all approaches to supplements should not be surprising 
- there is evidence suggesting that both under- and over-
methylation can pose health risks, for example, as can 
continuous anti-oxidant supplementation in those who 
don’t need it. However, it is the “shotgun” approach to 
supplementation that often poses the health problems. 
When viewed in the totality of evidence for individualised 
anti-oxidant or vitamin prescription, meta-analyses 
such as these suggest a problem not with supplements 
themselves, but rather their injudicious use by clinicians 
who are not adequately trained to apply the existing 
evidence to individual patient concerns. 
 Clinical justification for treatments
An obvious extension to individualised treatment 
is clinical justification of all treatments. Whilst the 
importance of using individualised evidence has been 
discussed in the previous point, the clinical justification for 
treatment extends beyond clinical reasoning to ensuring 
that practice is also ethical. This principle is based on 
ensuring that treatments are derived in a “conscientious, 
explicit and judicious” manner, not merely those 
based on personal preferences or interests. In CIM 
practice, practice dispensaries and the preponderance of 
availability of new diagnostic tests offer two case studies 
in how this may apply to clinical practice:
Practice dispensaries and in-clinic sales
As enthusiasm for (and possible pecuniary interest 
in) particular products can potentially cloud clinical 
judgement,12 CIM practitioners also need to be aware 
of how this may affect their own practice. Good EBM 
practice requires critical reflection on (and documentation 
of) the clinical justification of all treatments. The reason 
most conventional medicine physicians who are required 
to reimburse the government for incorrect claiming, have 
to do so is because they have failed to clinically justify 
their treatment (in their notes), not because the treatments 
they used were non-evidence-based. . This means that any 
prescription must be based entirely on what best serves the 
patient’s needs for their treatment, not merely the best of 
what is available in your personal dispensary. There may 
be advantages for both practitioner and patient in being 
able to dispense at the same site of the clinical consultation, 
but there are ethical and EBM obligations to explain to 
patients about how the practitioner’s available treatments 
compare to treatments available elsewhere, and to offer 
them the choice of procuring their prescription elsewhere 
if the best products are not available in your dispensary.12
Diagnostic tests
This requirement for clinical justification includes 
diagnostic tests. CIM practitioners now, more than ever, 
have unbridled access to a range of conventional and 
CIM-specific diagnostic tests more than ever before.13 
However, these need to be used judiciously. The use 
of expensive pathology “test panels” on every patient, 
sometimes as a requirement before the patient is even 
seen for the first consultation, is incongruent with EBM. 
Whilst very occasionally this ‘shotgun’ approach to 
pathology panels may pick up something that could not 
be elicited via good case-taking technique or physical 
examination, they are not an efficient use of patient time 
or money, or of the broader health system’s resources. No 
diagnostic test can replace a good case-taking technique 
or physical examination. In EBM, pathology tests should 
only be ordered to confirm clinical suspicions based 
on these foundational techniques, not in place of them. 
For example, if you are ordering a test, the obvious 
question to ask is “will the result make a difference to 
my treatment?” If not, there is no legitimate reason to 
order it, and all you are doing is exposing the patient to 
unnecessary cost, time wasting and discomfort. 
 Proper procedures
Although “mechanical rule following” is discouraged 
in real EBM, this does not mean that proper procedures and 
protocols should be discarded.8 EBM even acknowledges 
that the procedures and processes may differ according 
to levels of expertise. Whilst novice clinicians may work 
methodically and slowly through a long and standardised 
history, exhaustive physical examination and diagnostic 
tests, the expert clinician may make a rapid initial 
differential diagnosis through intuition, and then use more 
a selective history, examination and set of tests to rule 
in or rule out particular possibilities.8 The key similarity 
is that neither clinician relies on their knowledge or 
intuition alone, and has strategies that confirm or deny 
their initial assumptions in a conscientious, explicit and 
judicious manner.   
The importance of proper procedures and processes 
in EBM extends to the escalation of care. In clinical 
practice, more invasive, expensive or risky procedures 
and treatments should never be considered first, where 
less invasive, cheaper or safer procedures and treatments 
exist. In naturopathy, the therapeutic hierarchy14 offers 
guidance to treatment, and is itself an example of the sort 
of protocol encouraged by EBM. Similarly, no pathology 
test can replace a good case-taking technique or physical 
examination. Pathology tests should only ever be ordered 
once the information gathering ability from these other 
sources has been exhausted. 
Proper procedures must also be adhered to in relation 
to assessing evidence. Whilst most people assume 
‘evidence’ in EBM relates to the evidence supporting 
individual treatments, real EBM requires a risk-benefit 
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assessment for all treatments. This necessitates not only 
a critical evaluation of the potential therapeutic benefits 
of the treatments proposed, but also an assessment of the 
evidence for their risks. This risk-benefit assessment may 
change depending on individual patient circumstances. 
For example, a patient on a drug with a narrow therapeutic 
dose range (such as Warfarin) may be exposed to far 
more risk from potentially interactive treatments than 
a patient on a drug with a broader dose therapeutic 
range. Warfarin, for example, may necessitate additional 
investigation or monitoring even in patients being 
recommended ordinarily benign therapies such as onion 
or green tea.15 The spectrum of patient risk means that 
appropriate procedures concerning ‘red flag’ scenarios 
need to be incorporated into clinical practice.
The use of St John’s Wort (Hypericum perforatum) 
offers another example of how these procedures work 
in clinical practice. The potential interactions of this 
useful herb are well known, and should be obvious to 
any qualified and competent practitioner. Additionally, 
qualified and competent practitioners should know that 
the major clinical indication of the herb (depression) 
and its pharmacology (essentially a herbal selective 
serotonin reuptake inhibitor) make it increasingly likely 
to potentially duplicate a patient’s existing medications 
(conventional anti-depressants), a scenario which could 
result in a potentially serious adverse event (serotonin 
syndrome). EBM – and competent clinical practice – 
demand that, given the significant evidence at hand 
for potential risk, all patients with depression should 
be asked about conventional anti-depressant use, and 
warned about the duplication of St John’s Wort and 
conventional anti-depressants. 
Proper EBM procedures extend to using the evidence 
observed in patients themselves, particularly the results 
the patient exhibits in clinical practice, to inform 
continuing treatment. In 2008 the Australian Family 
Physician published a notable case where a naturopath 
had provided dangerous treatment to a patient, due to 
failure to observe this EBM procedure.16 The patient 
– a 72 year old male – had fallen off a horse while 
mustering cattle and injured his head four years earlier. 
Whilst he had sought medical treatment, none was 
necessary until he split his head open again. Although 
not concerned, it had been slow to heal, so he consulted 
a naturopath who packed the sore with Comfrey leaves 
and advised the patient to eat curry to aid with healing. 
This treatment progressed over 6 weeks, with weekly 
practitioner consults, during which time the wound got 
progressively worse. Eventually, the patient presented to 
hospital, where it was discovered that he had a massive 
10x11cm erosive lesion with pulsatile areas percolating 
frank blood, which had eroded through skull, soft tissue 
and down to the meninges. From an EBM perspective, 
the key issue here is not the initial treatment itself (as 
long as clinical judgement was made that this was an 
appropriate treatment for the patient, and was not likely 
to cause harm), but the fact that the practitioner ignored 
evidence at hand that the treatment was not working and 
that the condition was getting progressively worse, and 
continued a treatment that was clearly ineffective in this 
individual patient. 
Patient-centred outcomes
Real EBM is patient-centred. This, rather intuitively, 
simply means that outcomes from medical care are those 
that are important to patients, and is clearly apparent 
from ‘patient values and expectations’ forming an entire 
section of the EBM triad. Clinicians of all persuasions 
can be focused on what they see as clinically important 
outcomes, and real patient priorities may not always 
be apparent. Rheumatoid arthritis offers an insight 
into this disparity. Whilst most clinical attention, and 
research focus, had been on reducing and managing 
the pain associated with this condition, patients are 
generally more concerned with the crippling fatigue 
associated with the condition.17 Until qualitative work 
had uncovered this priority, most studies, and most 
treatment, had focused on what clinicians had thought 
was the obvious priority – pain. 
Real EBM requires that the patient be heard, and that 
the clinician treats actual patient priorities as identified 
by the patient, not just those the clinician believes are the 
most pertinent. The holistic and preventive focus of CIM 
offers a further interesting example of patient priorities 
that can often be overlooked. Some CIM clinicians may 
overlook immediate, acute or symptomatic treatment in 
favour of searching for the underlying cause that needs 
addressing. Whilst identifying the underlying cause 
remains essential, it is unlikely to be able to occur if the 
patient’s immediate concerns are not also met. A patient 
presenting with acute upper respiratory tract infection 
which is the result of reduced vitality caused by poor 
dietary and lifestyle behaviours is unlikely to comply 
with the dietary and lifestyle changes prescribed, if 
their acute symptoms are not adequately treated. Pain 
(for example dysmenorrhoea, migraine or rheumatoid 
arthritis) may have underlying triggers and exacerbating 
factors that can reduce the incidence, severity and impact 
on the patient long-term, but also require symptomatic 
relief during acute episodes. 
In some cases CIM can even be no better than 
conventional medicine at overlooking the patient in the 
application of care. In my lectures on this topic I often use 
a case from my own practice to illustrate this point. The 
patient was a shift-working nurse who for over 12 years 
had sought treatment from almost every type of CIM 
and conventional care practitioner available for what 
she described as ‘horrific’ dysmenorrhoea. All previous 
practitioners had categorised her as a ‘reproductive’ 
patient, and had treated her accordingly – ignoring 
the previous failures of all other practitioners taking 
this approach. However, upon consultation it became 
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apparent that the patient had digestive issues as well, 
and was only defecating every four days. This had been 
voluntary, and was the result of a mental and emotional 
response the patient had to defecation, which she viewed 
as a disgusting act. Her sessions were amended to 
provide counselling on the importance of elimination, 
the ‘natural-ness’ of the process and to educate her on 
the physiological processes of how this may affect her 
dysmenorrhoea. Once the patient had developed a more 
healthy attitude towards defecation, her symptoms 
resolved completely within two cycles. However, she had 
been seeking treatment unsuccessfully for over a decade 
simply because all previous practitioners had chosen 
to categorise the patient according to her condition (or, 
more accurately in this case, her symptom), rather than 
listen to her as an individual. 
In the area of reproductive medicine alone there 
are numerous other examples of CIM practitioners 
categorising patients into treatment categories (or even 
into individual treatments): too often CIM practitioners 
treat ‘endometriosis’ with the various ‘condition-specific’ 
treatments without exploring whether the underlying 
cause is hormonal, immune, genetic or related to 
some other condition;8 practitioners may ignore the 
potential differential diagnoses of anxiety or depression 
in premenstrual syndrome presentations, which can 
represent up to 30% of all presentations;19 or practitioners 
may ignore dietary and lifestyle modification in poly-
cystic ovarian syndrome, which is far more effective 
than any drug – natural or otherwise.20 Whilst some 
commentators may suggest that this is a result of CIM 
being ‘medicalised’ and ignoring philosophical tenets 
in favour of medical diagnosis and categorisation,5 I 
would wholeheartedly disagree. Even ‘traditional’- or 
‘philosophically’-based texts (such as King’s Dispensatory 
or the British Herbal Pharmacopeia in herbal medicine) 
categorise treatments by symptoms, not by patients. The 
error comes from individual clinicians ignoring the patient 
in their contextualisation and interpretation of evidence 
and information, not the method or ‘school’ by which they 
choose to treat the patient. 
What isn’t EBM?
There is no room in EBM practice of CIM for dogmatic 
opposition to conventional medicine. Iatrogenesis may be 
a major cause of disease burden, but this does not mean 
that the entirety of medicine is not without merit. Nor is 
iatrogenesis a concept limited to conventional medicine 
– it is also (relatively) common in CIM use, albeit at a 
lower level than observed in conventional medicine.21 
Nonetheless, many therapies – including invasive 
therapies such as chemotherapeutic oncological treatment 
– are unequivocally successful in many conditions, and 
combine well with CIM treatment (particular to address 
potential side effects). Opposing potentially effective 
conventional treatment simply because it is not ‘natural’ 
is not only potentially dangerous, it is also incongruent 
with EBM. An extension of this is the conspiracy theories 
that abound in CIM. There usually is no great conspiracy 
against CIM, and focusing on these as the cause of 
problems within the CIM and patient communities 
rather than the actual causes, not only hampers the CIM 
professions,22 but does not align with EBM. 
Other major common issues observed in some CIM 
professions that are inconsistent with EBM include 
a belief that CIM can fix everything. Every medicine 
has its limitations, and CIM is no exception. Similarly, 
there are no panaceas or miracle treatments that all 
patients need to be prescribed. EBM patient prescriptions 
need to be based on evidence applied to individual 
circumstances, not the latest product or therapy being 
promoted as the cure-all everyone needs. Last, but not 
least, is the tendency of a minority of practitioners to 
focus on their professional rights as a practitioner over 
their obligations to patients. Being a practitioner is not 
a right, but a privilege. The ‘right’ in regards to CIM 
belongs to patients, who have the right to a competent and 
qualified practitioner of their choice. With this privilege 
come substantial obligations and responsibilities, which 
include placing the patient at the centre of all clinical 
decision-making. This may include an often misplaced 
loyalty among the CIM professions to gather around 
those CIM practitioners or supporters who are under 
attack from ‘common’ enemies. Sometimes these attacks 
are justified, sometimes they are not. However, to support 
CIM practitioners who have ignored their obligations to 
patients, or have practised in an unsafe or incompetent 
manner, neither helps the profession nor represents EBM 
in practice. EBM requires that we support those being 
attacked when it is not justified, but that we do not defend 
unsafe, incompetent or unethical care simply because it is 
portrayed as ‘an attack against CIM’.
Is traditional medicine recognised as 
evidence?
Traditional knowledge, although often viewed as 
‘lower’ on the evidence hierarchy, is not discounted by 
EBM entirely. Traditional evidence, based on empirical 
observation over hundreds, sometimes thousands of 
years, can also be logically viewed as an extension of the 
‘clinician’s experience’ part of the EBM triad. However, 
there is growing international recognition of traditional 
medical knowledge as a source of evidence, as indicated in 
the World Health Organization’s most recent Traditional 
Medicine Strategy document.23 There are international 
efforts underway to codify this traditional knowledge 
for greater recognition. For example, both traditional 
Chinese medicine and chiropractic diagnoses are being 
standardised for incorporation into the upcoming version 
of the International Classification of Diseases which will 
give diagnoses from these medical traditions the same 
weight as ‘Western’ medical diagnoses.24 In the Australian 
courts, traditional use and practice is already recognised 
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as a form of admissible evidence, albeit at a lower 
level than scientific evidence.25 Similarly, traditional 
evidence is also accepted by the Therapeutic Goods 
Administration, with protections against its fraudulent 
use (such as a requirement that multiple generations of 
use be documented before allowing it to be used, so that 
traditions cannot be invented).26
There are numerous reasons for such recognition. Even 
among unrelated cultures with little history of interaction 
(such as China and indigenous Australia) there appears 
to be significant concordance of the therapeutic use of 
plant medicines native to both areas.27 Linguistic analysis 
suggests that Chinese medicine terminology often 
describes similar concepts to Western medicine, only in 
a different way and that Chinese medicine concepts have 
much in common with the syndromes and mnemonics 
used in Western medicine.28 Sometimes the wisdom 
of tradition, even when technically incorrect, can still 
proffer useful advice. The etymology of malaria is ‘bad 
air’ in medieval Italian, so named because of the belief 
in many traditions that the cause was due to the fetid air 
associated with swamplands (its old English name was 
‘marsh fever’).29 Whilst it is now known that mosquitos 
are the vector, avoidance of mosquito-ridden swamps, for 
whatever reason, was nonetheless an effective method of 
minimising exposure to the disease. 
Traditional knowledge is, in many ways, starting to be 
‘validated’ by science: For example, whilst attention to 
the importance of growing conditions on the medicinal 
quality of plants is being increasingly recognised, this was 
long a part of herbal practice. In his 17th century treatise 
Culpeper wrote of the conditions required for herbs to 
have optimal therapeutic qualities, noting in Colewort’s 
(Geum urbanum) case that “they rather delight to grow 
in shadowy than sunny place”.30 Modern science is only 
now confirming centuries of traditional knowledge, in 
demonstrating why Brahmi (Bacopa monnieri) displays 
different therapeutic qualities depending on when it is 
harvested in relation to annual monsoons.31 There are 
also practically important reasons for recognition of 
tradition. The recent ban on Kava (Piper mythesticum) 
in many countries was a response to the hepatotoxicity of 
a solvent-extracted German preparation. The traditional 
aqueous extraction does not extract these hepatotoxic 
compounds.32 Whilst the implementation within different 
countries varies considerably, for reasons such as these, 
groups such as the World Health Organization are 
recommending greater recognition of traditional medical 
knowledge, not less.23 
However, a reliance on traditional evidence alone is 
not enough in EBM. Just as an over-reliance on scientific 
evidence alone can result in practice being ‘tyrannised 
by evidence’, or an over-reliance on  clinical expertise 
alone can result in practice becoming ‘rapidly out of 
date’.7 Relying solely or too much on traditional evidence 
can present its own problems. Real EBM requires the 
totality of all forms of evidence to be considered in 
every clinical encounter. 
What went wrong? Why perceived tensions 
exists between CIM and EBM
Limitations and problems in EBM
There are noted limitations in the application of 
EBM. Clinicians may denounce that in many cases, the 
highest form of empirical study, the clinical trial, may 
not accurately reflect the true practice of therapies. There 
is a valid criticism that clinical trials too often measure 
the effects of therapies in a way that they are never going 
to be used (many trials require the intervention be used 
exclusively, or be applied to strictly controlled criteria 
rather than individual clinical judgement), in patients that 
are never going to be seen in a clinic (many trials exclude 
multi-morbidity and patients with numerous health 
risk factors unrelated to the clinical condition being 
investigated), by physicians who will never actually 
practise (many trials are carried out by researchers, not 
grassroots practitioners), in settings that don’t actually 
exist (many trials take place in research centres, rather 
than functioning clinics). Such criticisms are particularly 
pertinent to the CIM community, where the variation 
between research setting and ‘real-world’ practising 
environment may be particularly pronounced.33 
Such criticisms, however, do not stem solely from 
the CIM community. Whilst CIM often attracts enough 
criticism and controversy to promptly highlight issues 
of concern – serving somewhat as an ‘EBM canary in 
the coal mine’ – few therapies are found to be effective 
using narrow, dogmatic, reductionist approaches to 
EBM. For example, orthopaedic and sports medicine 
seems to have an even lower evidence-base than the 
CIM therapies recently included in the Australian private 
health insurance natural therapies review.34 Even primary 
care itself cannot survive this bastardised approach to 
EBM. Stange and colleagues draw attention to what 
they term the “primary care paradox”, noting that the 
complexities of primary care itself mean that its benefits 
can be obscured by dogmatic application of EBM, such 
as studies that focus on narrow controlled interventions 
(as opposed to the complex multiple individualised 
treatment approach of primary care) in patients that do not 
have ‘complexities’ such as multiple morbidities, are not 
taking other medications, and do not have confounders 
that may be considered problematic for clinical trials 
such as old age, young age, pregnancy or substance 
abuse .10 As such, the benefits of primary care can differ 
depending on which evidence is being interpreted: trial 
evidence fairly consistently shows that primary care 
clinicians deliver poorer quality care than specialists; 
evidence from the Medical Outcomes Study shows 
similar outcomes for specialists and generalists, but at 
lower cost for generalists (representing higher value); in 
studies of patients with chronic somatic and/or mental 
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illness, shared care between specialists and generalists is 
optimal; ecological studies find that a greater supply of 
generalists and a lower supply of specialists is associated 
with greater quality of care on multiple disease-specific 
quality measures; ecological studies show that more 
primary care is associated with better population health 
with lower cost and greater equity.10 
In many cases, however, EBM is incorrectly 
perceived to align only with the first form of evidence 
(trials), potentially obscuring the value of primary 
care. However, the other forms of evidence listed are 
becoming increasingly important in clinical and policy 
decision-making, and have also been suggested to more 
accurately reflect the true value of CIM therapies.35 
However, it should be noted that such developments may 
not – yet – be fully embraced by the conventional medical 
community (the well-publicised methodological flaws 
in recent NHMRC reviews of CIM being an obvious 
example), though they are likely to be so in the coming 
years (for example, the US government now mandates 
this broader evidence perspective be considered when 
assessing research proposals in federally funded schemes 
– with new schemes such as PCORI specifically aimed 
at developing these new evidence forms). There have 
also, undoubtedly, been problems with misappropriation 
of EBM by various vested interests, from fervent 
proponents pushing narrow interpretations of EBM to 
drug companies influencing the research process (via 
development of new research tools, publication bias 
and invention of new ‘conditions’ requiring treatment) 
to better push their own products via the EBM model.8 
These problems, however, aren’t due to EBM but rather 
its misappropriation and distortion by a vocal and 
influential minority.
The perceived conflict between CIM and 
EBM – is it really reflective?
The perceived conflict between CIM and EBM appears 
to be a side-effect of the political tensions between CIM 
and conventional medicine, rather than a true conflict or 
inability for CIM and EBM to align. The use of narrow 
(and false) interpretations of both EBM and science as 
blunt weapons against CIM by ideological opponents 
(for example, by labelling them pseudoscientific and 
incompatible with conventional medical principles) have 
probably led credence to this perceived conflict.36 As 
have CIM commentators, who have suggested that any 
move to embrace EBM by Australian naturopathy, for 
example, is driven solely by political factors, and that the 
idea of evidence-based medicine bypasses or minimises 
the philosophical and methodological foundations of 
naturopathy.5 Some commentators have attempted to 
further dissociate EBM and CIM as two distinct, separate 
and  opposite entities – suggesting, for example, that the 
upsurge in the use of integrative therapies by conventional 
medical practitioners is linked to their defence of 
clinical autonomy in the face of pressures to practice an 
‘approved’ version of evidence-based medicine.37 
However, the notion that the underlying beliefs of CIM 
practitioners are too philosophically divergent to engage 
with EBM does not fit the reality of perceptions of grass-
roots CIM practitioners and students. Australian studies of 
naturopathic students38 and practitioners 39 have suggested 
that CIM practitioners do in fact critically engage 
with both traditional and scientific forms of evidence, 
and modern CIM practitioners want information that 
both supports and is critical of traditional naturopathic 
practices. This aligns with Boon’s early Canadian work 
which suggested that CIM practitioners viewed treatment 
through a spectrum of scientific and holistic world-
views, and were able and willing to be more holistic or 
more scientific depending on patient needs,40 as well as 
international studies of the naturopathic profession’s 
attitudes towards EBM.41 It also aligns with data that 
suggests CIM professions in Australia – particularly 
Chinese medicine and naturopathy – are becoming more 
actively engaged and successful in health and medical 
research funding streams such as those of the National 
Health and Medical Research Council.42 
A lesson from naturopathic history
Additionally, the notion that CIM and EBM are 
incompatible does not reflect true tradition of CIMs. 
For example, the first article in the first journal of 
naturopathy in Australia not only celebrated the potential 
for scientific advancement to advance naturopathy 
practice, it also called upon scientists and practitioners 
to build an evidence base to inform safe and effective 
naturopathic care.43 This philosophy defined naturopathic 
practice until the late 1960s, when the counter-cultural 
movement began to appropriate naturopathy as a tool 
to reject conventional medical and scientific thought, 
and began to re-orient naturopathy as an ‘alternative’ 
modality focusing on ‘natural’ treatments rather than 
the ‘healing force of nature’ – defined by Baer as 
when “straight-backed nature cure met the flower 
children”.44 The linking of naturopathy with the counter-
cultural movement led to a growing popularisation of 
naturopathy, but also its establishment as a discipline 
defined as much by its opposition to the conventional 
medical and scientific models as it was by any coherent 
philosophy, and eventually became indistinguishable 
from the ‘natural treatment’ movement. 
However, whereas naturopathy had an underlying 
philosophical basis, ‘natural treatment’ was a negative, 
oppositional discipline with little philosophical base 
beyond a stated (though little realised in practice) belief 
in holism and a rejection of scientific and conventional 
medical principles. Gort and Coburn describe this also 
in relation to the Canadian naturopathic profession, 
noting that disconnection with philosophy and 
association with the counter-cultural movement had 
meant “naturopathy itself has been shaped by its status 
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as a marginal profession and has assumed oppositional 
postures irrelevant to its core doctrine and that has 
contributed to its marginal status”.45 Rejection of science 
and EBM is not a core doctrine of naturopathy, but 
rather a philosophical stance thrust upon the profession 
by vested interests that chose to co-opt the profession 
to push forward their own counter-cultural movement. 
Commentators may be right, in that there is distinct 
political advantage in naturopathy adopting EBM, but 
this is not at the expense of naturopathy’s philosophical 
or methodological foundations. Rather, it could be 
argued that adoption of real EBM by the naturopathic 
profession is one way in which those philosophical 
and methodological foundations can be restored, and 
that opposition to EBM does not reflect alignment with 
naturopathic philosophy at all. 
Where is the evidence?
The largest problem facing CIM is not the negative 
evidence suggesting that CIM does not work, but rather 
the paucity of evidence at all. Even more pressing is the 
need for research around the practice of CIM, which 
can highlight the valuable role of the CIM clinician in 
delivering care, rather than placing emphasis on the 
role of the therapy (e.g. herbal medicine, acupuncture, 
nutritional supplement) itself.35 However, it is not 
the role of the scientific community to build CIM’s 
evidence-base, but rather it is the CIM community’s 
obligation to build research capacity among its own 
clinicians, to build the evidence-base itself.46, 47 After 
all, no-one else can be expected to do it for us. Not only 
does this ensure that CIM has a foundation upon which 
to base EBM, but it also ensures that the evidence-
base is truly reflective of CIM practice and respectful 
of CIM traditions.48 This does not necessarily mean 
that clinicians should necessarily conduct their own 
projects, though this should be encouraged, but a 
culture of involvement in ongoing projects should be 
encouraged, whether that be involvement in surveys, 
focus groups, trials or initiatives such as practice-
based research networks (e.g. PRACI49). If the CIM 
community does not establish its own evidence 
base, the vacuum will be filled by the misinformed 
assumptions on CIM of groups like Friends of 
Science in Medicine, whose views will be lent more 
legitimacy than they deserve solely due to the fact that 
no opposing point of view has been established. This 
does not support the CIM professions, and it does not 
support good patient care.
Conclusion:
EBM, though often cast as a CIM ‘bogeyman’, is 
simply an extension of good clinical practice. The fear of 
embracing EBM in CIM appears to be related more to an 
over-simplified and dogmatic interpretation of EBM by 
both CIM proponents and opponents, but an interpretation 
that bears little resemblance to the true principles of 
EBM. EBM is a far more complex concept than we tend 
to give it credit for: ‘evidence’ is not synonymous with 
‘RCT’ – many other forms exist; scientific knowledge 
is not a substitute for traditional knowledge and vice 
versa, and traditional knowledge is not an ‘inferior’ 
or ‘undeveloped’ form of knowledge. Science and 
tradition can co-exist in EBM. They have different 
aims and structures, and make different contributions to 
knowledge. Professional opposition to EBM in the CIM 
professions has no philosophical or traditional base. In 
fact, it could be argued that only by embracing EBM, can 
CIM professions truly embrace their own philosophies 
and traditions.
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